… for treatment of early-stage breast cancer. There is increasing recognition that the care of a
… (above), Ki67 assessment will remain a necessary but less proven strategy for determining …

… Table 5 Crude Kaplan–Meier estimated survival probabilities according to St Gallen … In
this regard, further St Gallen International Breast Cancer Conferences have focused on a …

… /Vienna meeting remains the most important international breast cancer meeting on
European soil from a … Estimating the benefits of therapy for early-stage breast cancer: the St. …

… the St Gallen Consensus Conference aims to offer guidance to clinicians regarding appropriate
treatments for early-stage breast cancer and … can be characterized by determining grade, …

… Gallen International Breast Cancer Conference 2021 held virtually … Sixty percent of the panel
confirmed that estimation of … in ER-positive and HER2-negative early-stage breast cancer …

… For the use of immunotherapy in early-stage TNBC, we only have supporting evidence in
neoadjuvant settings so far. Recent clinical trials such as KEYNOTE-522, IMPASSION031, and …

… ALN status than those originally included in the Z0011, International Breast Cancer Study
Group 23-01, and AMAROS trials. … Estimating the benefits of therapy for early-stage breast …

… Gallen International Breast Cancer Conference that was held … has been diagnosed with early
stage breast cancer. They were … assay to help estimate likelihood of recurrence and benefit …

… Breast cancer is a heterogeneous disease with overexpression of several receptors, such …
is a prognostic and predictive biomarker for treatment with the anti-HER2 monoclonal antibody …

… aimed to estimate direct medical costs for early breast cancer care in … Estimating the benefits
of therapy for early-stage breast … Gallen international consensus guidelines for the primary …